Business · 23 Oct
Bharat Biotech slashes malaria vaccine price on GAVI-backed pact with UNICEF
AI summaryVaccine maker Bharat Biotech International announced a 40% price reduction for its malaria vaccine Mosqivac following a GAVI-backed agreement with UNICEF. The deal, supported by an advance payment from the International Finance Facility for Immunisation (IFFIm), will lower the price to €5.50 per dose effective early 2027, aiming to save $50 million for child immunisation programmes and reach one million more children. The article notes that demand for malaria vaccines has exceeded forecasts and that the vaccine is now part of routine immunisation in 25 African countries.
1 outlet
